NEC BIRMINGHAM
13-14 OCTOBER 2024

18 Jun 2024

NEWFOUNDLAND DIAGNOSTICS: REVOLUTIONISING HEALTHCARE ACCESS THROUGH AT-HOME TESTING

Newfoundland Diagnostics Stand: K70
Cut The Bull
NEWFOUNDLAND DIAGNOSTICS: REVOLUTIONISING HEALTHCARE ACCESS THROUGH AT-HOME TESTING
Michael Hodnett & Frederick Manduca, Newfoundand DIagnostics Co-Founders
100 Million Tests Sold Globally

LONDON, June 2024 - With strained healthcare systems and a growing emphasis on preventative care, Newfoundland Diagnostics, a leading provider of at-home diagnostic tests, has emerged as a trailblazer in revolutionising healthcare one test at a time.

Founded in 2021 by entrepreneurs Frederick Manduca and Michael Hodnett, this rapidly growing UK company is transforming how people take control of their personal health through affordable, accurate at-home diagnostic tests. 

Rising to prominence during the COVID-19 pandemic, Newfoundland Diagnostics has already delivered over 100 million tests globally, working with the NHS, Team GB, Tesco and more to make healthcare more accessible. Now, the company has set its sights on a broader
mission: empowering individuals to take charge of their wellbeing across a range of health concerns.

From fertility and cholesterol to bowel health screening and HIV, Newfoundland Diagnostics offers tests that deliver results in as little as two minutes with over 97% accuracy. This speed and accuracy make the self-testing brand a crucial first step in the healthcare journey, reducing unnecessary doctor visits and easing the NHS burden.

In just three years, Newfoundland Diagnostics has generated £134 million in revenue and established a retail presence in over 500 Tesco stores nationwide, alongside key retailers and UK pharmacy chain, Avicenna.

Frederick Manduca, Co-founder of Newfoundland Diagnostics, said: "Our vision goes beyond just providing tests. We're creating a self-diagnostic culture where people have the tools to understand their health and seek timely care."

Michael Hodnett, Co-founder of Newfoundland Diagnostics, said: "We're tackling barriers such as fear, stigma, and lack of education head-on."

"Partnering with the likes of the Terrence Higgins Trust and The Royal Marsden Hospital are about driving real change in how society approaches health."

Social responsibility is central to Newfoundland Diagnostics, as shown by its donation of 100,000 COVID-19 tests to communities in need through The Trussell Trust. As the company explores new areas, its core mission remains: to make self-testing a cornerstone of proactive, accessible healthcare for all.

Newfoundland Diagnostics currently offers tests for testing:

● Allergy (cats, dust & pollen)
● Bowel Health
● Cholesterol
● Coeliac
● Covid & Flu
● Drugs & Alcohol
● Gout
● HIV
● Iron Deficiency
● Kidney Health
● Male Fertility
● Menopause
● Ovulation
● Pregnancy
● Prostate Health
● Thyroid
● Stomach Ulcer
● Strep A
● UTI
● Vaginal Infection
● Vitamin D

For information on Newfoundland Diagnostics and its product range, please visit  https://www.newfoundland.io

View all Exhibitor News
Loading

OUR PARTNERS AND SPONSORS

Supported By

Sponsored By

Platinum App Sponsor

Education Partners

Official Media Partner

Official Digital Partner

Official Publications

Media Partners

Charity Partners

Official Covid & Flu Jab Training

Career Partner

Member Of